Acetaminophen Prop 65 Briefing Packet

FDA has determined that the currently available evidence does not support the conclusion that acetaminophen in FDA-regulated products causes cancer. Accordingly, a Proposition 65 cancer warning on the labeling of products containing acetaminophen would not be scientifically accurate, and such labeling would be false or misleading.